A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cancer Letters

• Publication date

  2012-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.canlet.2012.03.023PMID 22465052
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeted therapies for hepatocellular carcinoma.

  2011cited by this paper
• γ‐Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro‐apoptotic and chemosensitizing agent

  2011cited by this paper
• Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf.

  2011cited by this paper
• Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma.

  2011cited by this paper
• Inhibiting aberrant Stat3 function with molecular therapeutics: a progress report

  2011cited by this paper
• Identification of β-Escin as a Novel Inhibitor of Signal Transducer and Activator of Transcription 3/Janus-Activated Kinase 2 Signaling Pathway that Suppresses Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma Cells

  2010cited by this paper
• Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3

  2010influential reference
• Betulinic acid suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase SHP‐1 in human multiple myeloma cells

  2010cited by this paper
• A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies

  2010cited by this paper
• 5-Hydroxy-2-Methyl-1,4-Naphthoquinone, a Vitamin K3 Analogue, Suppresses STAT3 Activation Pathway through Induction of Protein Tyrosine Phosphatase, SHP-1: Potential Role in Chemosensitization

  2010cited by this paper
• Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or Lymphoma

  2010cited by this paper
• Suppression of Signal Transducer and Activator of Transcription 3 Activation by Butein Inhibits Growth of Human Hepatocellular Carcinoma In Vivo

  2010cited by this paper
• Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.

  2009cited by this paper
• Molecularly targeted therapy for hepatocellular carcinoma

  2009cited by this paper
• Inflammation and Liver Cancer

  2009cited by this paper
• The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008.

  2009cited by this paper
• Boswellic Acid Blocks Signal Transducers and Activators of Transcription 3 Signaling, Proliferation, and Survival of Multiple Myeloma via the Protein Tyrosine Phosphatase SHP-1

  2009cited by this paper
• Bortezomib Overcomes Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway*

  2009cited by this paper
• Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia.

  2009cited by this paper
• Bcl-2 family members as molecular targets in cancer therapy.

  2008cited by this paper
• Molecular targeted therapies in hepatocellular carcinoma

  2008cited by this paper
• Oncogene addiction.

  2008cited by this paper
• Sorafenib in advanced hepatocellular carcinoma.

  2008cited by this paper
• Epigenetic down-regulation of the suppressor of cytokine signaling 1 (Socs1) gene is associated with the STAT3 activation and development of hepatocellular carcinoma induced by methyl-deficiency in rats

  2008cited by this paper
• A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies

  2008cited by this paper
• Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells.

  2007cited by this paper
• Piercing the armor of hepatobiliary cancer: Bcl‐2 homology domain 3 (BH3) mimetics and cell death

  2007influential reference
• Targeting the Cytoplasmic and Nuclear Functions of Signal Transducers and Activators of Transcription 3 for Cancer Therapy

  2007influential reference
• Tumour immunology: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment

  2007cited by this paper
• Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis.

  2007cited by this paper
• Loss of SHP-1 tyrosine phosphatase expression correlates with the advanced stages of cutaneous T-cell lymphoma.

  2007cited by this paper
• Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.

  2006cited by this paper
• Inhibition of Growth and Metastasis of Human Hepatocellular Carcinoma by Antisense Oligonucleotide Targeting Signal Transducer and Activator of Transcription 3

  2006cited by this paper
• Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma.

  2006cited by this paper
• Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma.

  2006cited by this paper
• Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.

  2006cited by this paper
• Redox Control of Signal Transduction, Gene Expression and Cellular Senescence

  2004cited by this paper
• SHP‐1 suppresses cancer cell growth by promoting degradation of JAK kinases

  2003cited by this paper
• The function of the protein tyrosine phosphatase SHP-1 in cancer.

  2003cited by this paper
• Suppressors of cytokine signalling: SOCS

  2002cited by this paper
• Bcl-xL overexpression in human hepatocellular carcinoma.

  2002cited by this paper
• Expression and role of Bcl‐xL in human hepatocellular carcinomas

  2001cited by this paper
• Bcl-2 family proteins as targets for anticancer drug design

  2000cited by this paper
• Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes.

  1991cited by this paper

• Obatoclax enhances TRAIL-induced apoptosis in non-small-cell-lung-cancer cells by increasing TRAIL receptor expression, priming for mitochondrial apoptosis and reducing XIAP levels

  2025cites this paper
• Obatoclax Rescues FUS-ALS Phenotypes in iPSC-Derived Neurons by Inducing Autophagy

  2023cites this paper
• Systemic lupus erythematosus: From non-coding RNAs to exosomal non-coding RNAs.

  2023cites this paper
• SHP-1 alleviates atrial fibrosis in atrial fibrillation by modulating STAT3 activation

  2023cites this paper
• Leonurine ameliorates the STAT3 pathway through the upregulation of SHP-1 to retard the growth of hepatocellular carcinoma cells.

  2023cites this paper
• Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges

  2022cites this paper
• The phosphatase Shp1 interacts with and dephosphorylates cortactin to inhibit invadopodia function

  2021cites this paper
• Circular RNA-0007059 protects cell viability and reduces inflammation in a nephritis cell model by inhibiting microRNA-1278/SHP-1/STAT3 signaling

  2021cites this paper
• SHP-1/STAT3 Interaction Is Related to Luteolin-Induced Myocardial Ischemia Protection

  2021cites this paper
• Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer

  2020cites this paper
• Y‐box protein 1 promotes hypoxia/reoxygenation‐ or ischemia/reperfusion‐induced cardiomyocyte apoptosis via SHP‐1‐dependent STAT3 inactivation

  2020influential citation
• Immunosuppressive receptor LILRB1 acts as a potential regulator in hepatocellular carcinoma by integrating with SHP1

  2020cites this paper
• Lycorine exerts antitumor activity against osteosarcoma cells in vitro and in vivo xenograft model through the JAK2/STAT3 pathway

  2019cites this paper
• TRIM52 promotes colorectal cancer cell proliferation through the STAT3 signaling

  2019cites this paper
• SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.

  2018cites this paper
• Molecular and Genomic Landscape of Peripheral T-Cell Lymphoma.

  2018cites this paper
• The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1

  2018cites this paper
• The Roles of Protein Tyrosine Phosphatases in Hepatocellular Carcinoma

  2018cites this paper
• Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening

  2018cites this paper
• Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers

  2018cites this paper
• Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1

  2018cites this paper
• Function of myeloid cell leukaemia-1 and its regulative relations with hepatocellular carcinoma

  2017cites this paper
• Suppression of PTPN6 exacerbates aluminum oxide nanoparticle-induced COPD-like lesions in mice through activation of STAT pathway

  2017cites this paper
• The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells

  2017cites this paper
• Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism

  2017cites this paper
• Sorafenib analogue SC‐60 induces apoptosis through the SHP‐1/STAT3 pathway and enhances docetaxel cytotoxicity in triple‐negative breast cancer cells

  2017cites this paper
• Targeted Therapy for Hepatocellular Carcinoma.

  2016cites this paper
• Implication of protein tyrosine phosphatase SHP-1 in cancer-related signaling pathways.

  2016cites this paper
• Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells

  2016cites this paper
• The BH3 Mimetic Obatoclax Accumulates in Lysosomes and Causes Their Alkalinization

  2016cites this paper
• Hippocalcin Promotes Neuronal Differentiation and Inhibits Astrocytic Differentiation in Neural Stem Cells

  2016cites this paper
• The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations.

  2016cites this paper
• Chapter 5 STAT 3 Inhibitors in Cancer : A Comprehensive Update

  2016cites this paper
• STAT3 Inhibitors in Cancer: A Comprehensive Update

  2016cites this paper
• Alternative treatments for melanoma: targeting BCL-2 family members to de-bulk and kill cancer stem cells

  2015cites this paper
• Pharmacological Targeting SHP-1-STAT3 Signaling Is a Promising Therapeutic Approach for the Treatment of Colorectal Cancer12

  2015cites this paper
• Differences in antiproliferative effect of STAT3 inhibition in HCC cells with versus without HBV expression.

  2015cites this paper
• Chemical composition of total flavonoids from Polygonum amplexicaule and their pro-apoptotic effect on hepatocellular carcinoma cells: Potential roles of suppressing STAT3 signaling.

  2015cites this paper
• Copper-obatoclax derivative complexes mediate DNA cleavage and exhibit anti-cancer effects in hepatocellular carcinoma.

  2015cites this paper
• RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells.

  2014cites this paper
• Possible Involvement of Signal Transducer and Activator of Transcription-3 (STAT3) Signaling Pathway in the Initiation and Progression of Hepatocellular Carcinoma

  2014cites this paper
• SC-2001 Overcomes STAT3-mediated Sorafenib Resistance through RFX-1/SHP-1 Activation in Hepatocellular Carcinoma

  2014cites this paper
• RFX1–dependent activation of SHP-1 induces autophagy by a novel obatoclax derivative in hepatocellular carcinoma cells

  2014cites this paper
• Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells

  2014cites this paper
• SHP-1 is a target of regorafenib in colorectal cancer

  2014cites this paper
• Targeting the BH3 domain of Bcl-2 family proteins. A brief history from natural products to foldamers as promising cancer therapeutic avenues.

  2013cites this paper
• Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma.

  2013cites this paper
• Huh-7 Human Liver Cancer Cells: A Model System to Understand Hepatocellular Carcinoma and Therapy

  2013cites this paper
• Obatoclax, Saliphenylhalamide, and Gemcitabine Inhibit Influenza A Virus Infection*

  2012cites this paper